Roivant Sciences President & CIO Mayukh Sukhatme Withholds Shares for Tax Obligations

Executive Summary

On October 2, 2026, Roivant Sciences Ltd. ($ROIV) filed a Form 4 on behalf of Mayukh Sukhatme, the company's President & Chief Investment Officer and Director. The filing discloses a disposition of 46,879 Common Shares on September 30, 2026, at a price of $36.57 per share, totaling approximately $1.71 million.

Transaction Details

• Security: Common Shares
• Transaction Code: F (Tax withholding / net settlement)
• Shares Disposed: 46,879
• Price Per Share: $36.57
• Gross Transaction Value: $1,714,365.03
• Nature of Ownership: Direct
• Ending Direct Holdings: 18,583,860 shares

Context and Analysis

According to Footnote 1, the transaction represents a "net settlement" by the Issuer of previously granted RSUs to satisfy statutory tax withholding obligations arising from vesting. It does not reflect an open-market sale or discretionary decision to reduce exposure to the company. Following this administrative disposition, Dr. Sukhatme continues to retain a substantial holding of 18,583,860 common shares, representing an immaterial dilution of his direct position (<0.3%). Consequently, the trading significance of this filing is categorized as Low.